These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18456848)

  • 1. In silico and in vivo evaluation of bacteriophage phiEF24C, a candidate for treatment of Enterococcus faecalis infections.
    Uchiyama J; Rashel M; Takemura I; Wakiguchi H; Matsuzaki S
    Appl Environ Microbiol; 2008 Jul; 74(13):4149-63. PubMed ID: 18456848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of a novel Enterococcus faecalis bacteriophage phiEF24C as a therapeutic candidate.
    Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Akechi K; Muraoka A; Wakiguchi H; Matsuzaki S
    FEMS Microbiol Lett; 2008 Jan; 278(2):200-6. PubMed ID: 18096017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage phiEF24C.
    Uchiyama J; Takemura I; Hayashi I; Matsuzaki S; Satoh M; Ujihara T; Murakami M; Imajoh M; Sugai M; Daibata M
    Appl Environ Microbiol; 2011 Jan; 77(2):580-5. PubMed ID: 21097580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved adsorption of an Enterococcus faecalis bacteriophage ΦEF24C with a spontaneous point mutation.
    Uchiyama J; Takemura I; Satoh M; Kato S; Ujihara T; Akechi K; Matsuzaki S; Daibata M
    PLoS One; 2011; 6(10):e26648. PubMed ID: 22046321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
    Kishimoto T; Ishida W; Fukuda K; Nakajima I; Suzuki T; Uchiyama J; Matsuzaki S; Todokoro D; Daibata M; Fukushima A
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage-Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against
    Topka-Bielecka G; Nejman-Faleńczyk B; Bloch S; Dydecka A; Necel A; Węgrzyn A; Węgrzyn G
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33669643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Enterococcus faecalis phage IME-EF1 and its endolysin.
    Zhang W; Mi Z; Yin X; Fan H; An X; Zhang Z; Chen J; Tong Y
    PLoS One; 2013; 8(11):e80435. PubMed ID: 24236180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and genome analysis of novel phage vB_EfaP_IME195 infecting Enterococcus faecalis.
    Wang R; Xing S; Zhao F; Li P; Mi Z; Shi T; Liu H; Tong Y
    Virus Genes; 2018 Dec; 54(6):804-811. PubMed ID: 30387031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the novel Enterococcus faecalis phage: A comprehensive genome analysis.
    Abed S; Sholeh M; Khazani Asforooshani M; Shafiei M; Hashemi Shahraki A; Nasr S
    PLoS One; 2024; 19(5):e0301292. PubMed ID: 38743671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.
    Duerkop BA; Huo W; Bhardwaj P; Palmer KL; Hooper LV
    mBio; 2016 Aug; 7(4):. PubMed ID: 27578757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a novel bacteriophage φ4D lytic against Enterococcus faecalis strains.
    Parasion S; Kwiatek M; Mizak L; Gryko R; Bartoszcze M; Kocik J
    Curr Microbiol; 2012 Sep; 65(3):284-9. PubMed ID: 22669253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci.
    Chatterjee A; Johnson CN; Luong P; Hullahalli K; McBride SW; Schubert AM; Palmer KL; Carlson PE; Duerkop BA
    Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936157
    [No Abstract]   [Full Text] [Related]  

  • 13. The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains.
    D'Andrea MM; Frezza D; Romano E; Marmo P; Henrici De Angelis L; Perini N; Thaller MC; Di Lallo G
    J Glob Antimicrob Resist; 2020 Jun; 21():68-75. PubMed ID: 31678321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete genome sequence of bacteriophage BC-611 specifically infecting Enterococcus faecalis strain NP-10011.
    Horiuchi T; Sakka M; Hayashi A; Shimada T; Kimura T; Sakka K
    J Virol; 2012 Sep; 86(17):9538-9. PubMed ID: 22879611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P087, a lactococcal phage with a morphogenesis module similar to an Enterococcus faecalis prophage.
    Villion M; Chopin MC; Deveau H; Ehrlich SD; Moineau S; Chopin A
    Virology; 2009 May; 388(1):49-56. PubMed ID: 19349056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of φEf-vB1 prophage infecting oral
    Askora A; El-Telbany M; El-Didamony G; Ariny E; Askoura M
    J Med Microbiol; 2020 Sep; 69(9):1151-1168. PubMed ID: 32840477
    [No Abstract]   [Full Text] [Related]  

  • 17. vB_EfaS-DELF1, a novel Siphoviridae bacteriophage with highly effective lytic activity against vancomycin-resistant Enterococcus faecalis.
    Soleimani-Delfan A; Bouzari M; Wang R
    Virus Res; 2021 Jun; 298():198391. PubMed ID: 33737153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Bacteriophages with Therapeutic Potential That Target
    Al-Zubidi M; Widziolek M; Court EK; Gains AF; Smith RE; Ansbro K; Alrafaie A; Evans C; Murdoch C; Mesnage S; Douglas CWI; Rawlinson A; Stafford GP
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31451618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Phage Therapy in the Context of
    Bolocan AS; Upadrasta A; Bettio PHA; Clooney AG; Draper LA; Ross RP; Hill C
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31010053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic modifications to temperate Enterococcus faecalis phage Ef11 that abolish the establishment of lysogeny and sensitivity to repressor, and increase host range and productivity of lytic infection.
    Zhang H; Fouts DE; DePew J; Stevens RH
    Microbiology (Reading); 2013 Jun; 159(Pt 6):1023-1035. PubMed ID: 23579685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.